| 2026-01-12 | -61.8% | news | Stock Titan | Lab conferences boost CoSara's India network for future TB PCR tests - Stock Titan |
| 2026-01-12 | -61.8% | news | marketscreener.com | Co-Diagnostics, Inc.(OTCPK: CODX) dropped from NASDAQ Composite Index - marketscreener.com |
| 2025-10-28 | -61.1% | news | PR Newswire | Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - PR Newswire |
| 2025-10-28 | -61.1% | news | Investing.com | Co-Diagnostics stock plummets after announcing $7 million offering - Investing.com |
| 2025-10-28 | -61.1% | analyst | GuruFocus | Co-Diagnostics (CODX) Maintains Buy Rating, Target Price Unchanged | CODX Stock News - GuruFocus |
| 2025-10-28 | -61.1% | news | Investing.com | Co-Diagnostics announces $7 million registered direct offering - Investing.com |
| 2025-10-28 | -61.1% | news | marketscreener.com | Co-Diagnostics announces pricing of $7.0 million registered direct offering of common stock priced at-the-market under Nasdaq rules - marketscreener.com |
| 2025-10-28 | -61.1% | news | Benzinga | Why Celestica Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga |
| 2025-10-27 | +60.9% | news | Yahoo Finance | EXCLUSIVE: Co-Diagnostics Inks JV With Saudi Arabia Firm For Middle East Market - Yahoo Finance |
| 2025-10-27 | +60.9% | news | Investing.com | Co-Diagnostics stock soars after Saudi Arabia joint venture announcement - Investing.com |
| 2025-10-27 | +60.9% | news | Stock Titan | Co-Diagnostics (NASDAQ: CODX) signs Saudi JV to localize and manufacture Co-Dx PCR in MENA - Stock Titan |
| 2025-10-27 | +60.9% | news | Benzinga | Co-Diagnostics Stock Is Rocketing Higher Monday: What's Going On? - Benzinga |
| 2025-10-27 | +60.9% | news | Investorideas.com | CODX) Leads Nasdaq Top Gainers on new Saudi-based CoMira Diagnostics joint venture - Investorideas.com |
| 2025-10-27 | +60.9% | news | Stocktwits | CODX Stock Jumped A Whopping 148% Today: What’s Driving The Super Rally? - Stocktwits |
| 2025-10-27 | +60.9% | earnings | Benzinga | Gold Falls 3%; Carter's Shares Gain After Q3 Earnings - Benzinga |
| 2026-03-10 | +48.9% | legal | SEC EDGAR | CODX 8-K: 2.02 and 8.01 (SEC Filing) |
| 2026-03-10 | +48.9% | news | PR Newswire | Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - PR Newswire |
| 2026-03-10 | +48.9% | news | Stock Titan | Co-Diagnostics (NASDAQ: CODX) cleared to resume trading on Nasdaq - Stock Titan |
| 2026-03-10 | +48.9% | news | Investing.com | Co-Diagnostics regains Nasdaq listing compliance - Investing.com |
| 2026-01-13 | -43.3% | news | Investing.com | Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market - Investing.com |
| 2026-01-13 | -43.3% | news | TradingView | Co-Diagnostics Received Notice of Delisting - TradingView |
| 2026-01-13 | -43.3% | news | TipRanks | Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance - TipRanks |
| 2026-01-13 | -43.3% | news | Stock Titan | Co-Diagnostics (NASDAQ: CODX) set for Nasdaq suspension, eyes OTC move - Stock Titan |
| 2026-01-13 | -43.3% | news | Investing.com South Africa | Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market By Investing.com - Investing.com South Africa |
| 2026-03-11 | -38.6% | news | Investing.com Nigeria | Co-Diagnostics regains Nasdaq listing compliance By Investing.com - Investing.com Nigeria |
| 2022-08-11 | -34.0% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-30 | -25.3% | news | Seeking Alpha | Co-Diagnostics announces 1-for-30 reverse stock split |
| 2025-12-30 | -25.3% | news | PR Newswire | Co-Diagnostics Announces Reverse Stock Split - PR Newswire |
| 2025-12-30 | -25.3% | news | Investing.com | Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com |
| 2025-12-30 | -25.3% | news | Investing.com | Co-Diagnostics announces 1-for-30 reverse stock split - Investing.com |
| 2025-12-30 | -25.3% | news | Stocktwits | CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits |
| 2025-01-07 | -21.5% | executive | Stock Titan | Co-Diagnostics CEO to Showcase Revolutionary PCR Platform at Nasdaq MarketSite Broadcast - Stock Titan |
| 2025-08-15 | +21.0% | earnings | Yahoo Finance | Co-Diagnostics Inc (CODX) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance |
| 2025-08-15 | +21.0% | analyst | GuruFocus | Co-Diagnostics (CODX) Stock Rating Maintained at Buy by Analyst - GuruFocus |
| 2025-08-15 | +21.0% | executive | Stock Titan | Co-Diagnostics (CODX) CEO Dwight Egan Receives 275K RSUs; Vesting Schedule Disclosed - Stock Titan |
| 2025-03-27 | -21.0% | news | Seeking Alpha | Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa |
| 2025-03-27 | -21.0% | earnings | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript |
| 2025-03-27 | -21.0% | earnings | Seeking Alpha | Co-Diagnostics GAAP EPS of -$1.24 misses by $0.02, revenue of $3.91M misses by $0.23M |
| 2025-03-27 | -21.0% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-27 | -21.0% | news | PR Newswire | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - PR Newswire |
| 2025-03-28 | -19.6% | earnings | Investing.com India | Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 - Investing.com India |
| 2022-05-12 | +18.7% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-01 | -18.0% | earnings | Moby | Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary |
| 2026-04-01 | -18.0% | earnings | GuruFocus.com | Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... |
| 2026-04-01 | -18.0% | earnings | Seeking Alpha | Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options |
| 2026-04-01 | -18.0% | earnings | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript |
| 2026-04-01 | -18.0% | news | Cổng thông tin điện tử Tỉnh Sơn La | CODX Stock Analysis: Co-Diagnostics Inc. Drops 10.75% to $1.66, Key Support and Catalyst Outlook - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-01 | -18.0% | news | Xã Thanh Hà | CODX Stock Analysis: Co-Diagnostics Inc. Drops 10.75% to $1.66, Key Support and Catalyst Outlook - Xã Thanh Hà |
| 2022-03-15 | +17.8% | legal | SEC EDGAR | CODX 8-K: 7.01 and 8.01 (SEC Filing) |
| 2025-02-24 | -16.9% | legal | Yahoo Finance | Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Yahoo Finance |
| 2025-10-29 | -16.8% | legal | SEC EDGAR | CODX 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-10-29 | -16.8% | expansion | TipRanks | Co-Diagnostics Announces $7M Securities Purchase Agreement - TipRanks |
| 2025-10-29 | -16.8% | news | The Economic Times | US Stock Market top gainers and losers on October 28: ReNew Energy Global sees 240% jump, Co-Diagnostics, - The Economic Times |
| 2025-05-14 | -16.4% | news | Intellectia AI | CODX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2021-05-14 | +16.2% | analyst | Benzinga | Co-Diagnostics Analyst Ratings and Price Targets | NASDAQ:CODX - Benzinga |
| 2024-06-14 | -15.6% | legal | SEC EDGAR | CODX 8-K: 8.01 and (SEC Filing) |
| 2023-03-16 | -15.0% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-06 | +14.8% | earnings | PR Newswire | Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit - PR Newswire |
| 2025-11-13 | -14.7% | earnings | Seeking Alpha | Co-Diagnostics GAAP EPS of -$0.16, revenue of $0.15M |
| 2025-11-13 | -14.7% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-13 | -14.7% | earnings | Yahoo Finance | Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance |
| 2025-11-13 | -14.7% | news | PR Newswire | Co-Diagnostics Reports Third Quarter 2025 Financial Results - PR Newswire |
| 2025-10-31 | -14.2% | earnings | Yahoo Finance | Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast - Yahoo Finance |
| 2025-11-14 | -14.1% | earnings | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Q3 2025 Earnings Call Transcript |
| 2025-03-26 | -13.9% | earnings | Seeking Alpha | Co-Diagnostics Q4 2024 Earnings Preview |
| 2026-03-20 | -13.3% | news | NewMediaWire | Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia |
| 2026-03-20 | -13.3% | expansion | PR Newswire | Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia |
| 2026-03-20 | -13.3% | news | Stock Titan | Four new South Asian markets lift Co-Diagnostics' target to $13B - Stock Titan |
| 2026-03-20 | -13.3% | news | Quiver Quantitative | Co-Diagnostics jumps as it expands South Asia distribution footprint - Quiver Quantitative |
| 2026-03-20 | -13.3% | expansion | timothysykes.com | Co-Diagnostics Inc.’s Stock Surges Amid Strategic Moves and Partnerships - timothysykes.com |
| 2026-03-20 | -13.3% | news | StocksToTrade | ## Recent Developments: Key Market Insights - StocksToTrade |
| 2026-03-20 | -13.3% | news | timothysykes.com | Co-Diagnostics Latest Moves Juice International Hopes - timothysykes.com |
| 2026-03-20 | -13.3% | earnings | Benzinga | Nasdaq Down Over 1%; XPeng Shares Fall After Q4 Results - Benzinga |
| 2021-05-13 | +13.0% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-08-14 | +12.0% | news | Seeking Alpha | Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform |
| 2025-08-14 | +12.0% | earnings | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Q2 2025 Earnings Conference Call Transcript |
| 2025-08-14 | +12.0% | earnings | Seeking Alpha | Co-Diagnostics GAAP EPS of -$0.23 beats by $0.02, revenue of $0.16M misses by $0.14M |
| 2025-08-14 | +12.0% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-08-14 | +12.0% | legal | PR Newswire | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results - PR Newswire |
| 2025-05-29 | -12.0% | news | Intellectia AI | CODX Forecast — Price Prediction for 2026. Should I Buy CODX? - Intellectia AI |
| 2025-02-21 | -11.5% | legal | SEC EDGAR | CODX 8-K: 8.01 and (SEC Filing) |
| 2026-03-12 | -11.5% | news | Stock Titan | Japan patent backs Co-Diagnostics' compact PCR device for rapid infection tests - Stock Titan |
| 2021-11-12 | +11.1% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-08-10 | -10.7% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-03-15 | -10.5% | legal | SEC EDGAR | CODX 8-K: 5.02 and (SEC Filing) |
| 2021-08-12 | +10.5% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-03-24 | -10.4% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-25 | -9.8% | earnings | PR Newswire | Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization |
| 2026-03-25 | -9.8% | earnings | PR Newswire | Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization - PR Newswire |
| 2026-03-25 | -9.8% | expansion | Benzinga | EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch - Benzinga |
| 2024-05-09 | -9.7% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-24 | -9.6% | analyst | GuruFocus | HC Wainwright Reiterates Neutral Rating for Co-Diagnostics (CODX - GuruFocus |
| 2024-09-05 | +9.1% | news | Seeking Alpha | Singapore announces quarantine measures for close contacts of mpox infected patients |
| 2024-08-20 | -8.9% | news | Seeking Alpha | Mpox stocks pare recent gains in Tuesday trading |
| 2024-08-20 | -8.9% | news | Seeking Alpha | Mpox Stocks Have Popped, But Pickings Are Slim For The Discerning Investor |
| 2022-08-15 | -8.9% | news | The Motley Fool | Why Co-Diagnostics Stock Slipped Today - The Motley Fool |
| 2026-04-16 | +8.4% | expansion | PR Newswire | Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. |
| 2026-04-16 | +8.4% | news | Stock Titan | Tuberculosis test heads to Washington summit as Co-Diagnostics joins TB push - Stock Titan |
| 2026-03-31 | -8.4% | news | PR Newswire | Co-Diagnostics Reports Full Year 2025 Financial Results |
| 2026-03-31 | -8.4% | earnings | Seeking Alpha | Co-Diagnostics GAAP EPS of -$35.25 misses by $14.25, revenue of $0.6M beats by $0.12M |
| 2026-03-31 | -8.4% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-31 | -8.4% | news | PR Newswire | Co-Diagnostics Reports Full Year 2025 Financial Results - PR Newswire |
| 2026-03-31 | -8.4% | earnings | Stock Titan | Co-Diagnostics (NASDAQ: CODX) 2025 revenue plunges as cash declines - Stock Titan |
| 2026-03-31 | -8.4% | earnings | Investing.com | Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% - Investing.com |
| 2026-03-31 | -8.4% | earnings | Quiver Quantitative | Co-Diagnostics (CODX) Releases Q4 2025 Earnings: Revenue Down, Net Loss Widens | CODX Stock News - Quiver Quantitative |
| 2024-03-14 | -8.1% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-09 | -8.1% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-18 | +8.0% | news | AD HOC NEWS | Co-Diagnostics Shares Transition to Over-the-Counter Trading - AD HOC NEWS |
| 2023-12-11 | -7.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-18 | +7.3% | news | UBND thành phố Hải Phòng | Co-Diag (CODX) Stock: Undervalued vs Overpriced (+6.85%) 2026-04-18 - Undervalued Stocks - UBND thành phố Hải Phòng |
| 2024-11-07 | -7.0% | earnings | Seeking Alpha | Co-Diagnostics GAAP EPS of -$0.32 beats by $0.01, revenue of $0.64M beats by $0.26M |
| 2024-11-07 | -7.0% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-05-09 | -6.8% | earnings | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript |
| 2026-03-17 | -6.5% | news | Stock Titan | Co-Diagnostics sets Mar. 31 webcast to review 2025 results - Stock Titan |
| 2021-12-23 | +5.9% | legal | SEC EDGAR | CODX 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2026-04-02 | -5.8% | news | PR Newswire | Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City |
| 2026-04-02 | -5.8% | news | Stock Titan | Saudi Arabia clears industrial site for local molecular testing plant - Stock Titan |
| 2024-11-06 | -5.8% | earnings | Seeking Alpha | Co-Diagnostics Q3 2024 Earnings Preview |
| 2025-07-11 | +5.3% | legal | SEC EDGAR | CODX 8-K: 8.01 (SEC Filing) |
| 2026-04-11 | +4.9% | news | Quiver Quantitative | CODX | Co-Diagnostics, Inc. Common Stock Insider Trading - Quiver Quantitative |
| 2026-04-15 | +4.8% | news | Cổng thông tin điện tử tỉnh Lào Cai | Co-Diag (CODX) Stock Resistance Rejection (Bullish Sentiment) 2026-04-15 - Most Watched Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-11-05 | +4.7% | news | Yahoo Finance | Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd - Yahoo Finance |
| 2025-11-05 | +4.7% | news | Investing.com | Co-Diagnostics explores strategic options for Indian joint venture - Investing.com |
| 2025-02-27 | -4.6% | news | Seeking Alpha | WHO maintains public health emergency alert on mpox |
| 2025-11-06 | +4.5% | news | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments Transcript |
| 2025-09-18 | +4.4% | legal | SEC EDGAR | CODX 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-04-14 | -4.1% | news | PR Newswire | Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany |
| 2026-04-14 | -4.1% | news | Stock Titan | Co-Diagnostics to show new PCR platform at Munich infection meeting - Stock Titan |
| 2025-11-12 | -4.0% | earnings | Seeking Alpha | Co-Diagnostics Q3 2025 Earnings Preview |
| 2025-08-13 | +4.0% | earnings | Seeking Alpha | Co-Diagnostics Q2 2025 Earnings Preview |
| 2025-04-24 | -4.0% | news | Stock Titan | CODX Stock Price, News & Analysis - Stock Titan |
| 2026-03-30 | +3.7% | earnings | Seeking Alpha | Co-Diagnostics Q4 2025 Earnings Preview |
| 2024-08-31 | -3.7% | legal | Seeking Alpha | UNICEF issues emergency tender to secure mpox vaccines |
| 2025-10-20 | +3.6% | legal | SEC EDGAR | CODX 8-K: 1.01, 1.02 (SEC Filing) |
| 2024-09-06 | -3.5% | news | Seeking Alpha | Applied DNA stock jumps amid U.S. government mpox update |
| 2025-05-08 | -3.4% | earnings | Seeking Alpha | Co-Diagnostics GAAP EPS of -$0.24 beats by $0.03, revenue of $0.05M misses by $0.14M |
| 2025-05-08 | -3.4% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-05-11 | -3.2% | earnings | MarketBeat | Co-Diagnostics (CODX) Stock Forecast and Price Target 2026 - MarketBeat |
| 2025-12-31 | +3.0% | news | Yahoo Finance | Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance |
| 2025-12-31 | +3.0% | news | Yahoo Finance | CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Yahoo Finance |
| 2025-12-31 | +3.0% | news | MSN | CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN |
| 2024-11-23 | -2.3% | news | Seeking Alpha | WHO extends mpox emergency; Canada reports first clade I case |
| 2022-11-10 | +2.3% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-09 | -1.9% | earnings | PR Newswire | Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah |
| 2026-04-09 | -1.9% | earnings | Stock Titan | Utah trade mission puts Co-Diagnostics in meetings with Roche, UBS - Stock Titan |
| 2026-04-09 | -1.9% | earnings | PR Newswire | Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah - PR Newswire |
| 2024-08-08 | +1.9% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-02-21 | +1.8% | news | Seeking Alpha | Co-Diagnostics (CODX) Stock: Don't Buy On Cash Reserves Alone - Seeking Alpha |
| 2025-04-28 | +1.6% | legal | SEC EDGAR | CODX 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-02-05 | -1.5% | news | Stock Titan | India grants license for CoSara PCR device; TB, HPV tests pending - Stock Titan |
| 2026-04-13 | -1.5% | news | UBND thành phố Hải Phòng | Is Co-Diag (CODX) Stock Undervalued Now | Price at $1.39, Up 1.09% - Top Picks - UBND thành phố Hải Phòng |
| 2023-05-11 | +1.4% | legal | SEC EDGAR | CODX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-03 | +1.3% | news | Stock Titan | Can New HPV Testing Technology Help Reduce 350,000 Annual Cervical Cancer Deaths? - Stock Titan |
| 2022-12-19 | -0.9% | analyst | TradingView | CODX Forecast — Price Target — Prediction for 2027 - TradingView |
| 2026-02-09 | +0.9% | news | Stock Titan | Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders - Stock Titan |
| 2026-04-03 | -0.8% | news | Cổng thông tin điện tử tỉnh Lào Cai | CODX Stock Analysis: Co-Diagnostics Inc. falls 4.94% to $1.54, key support levels in focus - Cổng thông tin điện tử tỉnh Lào Cai |
| 2023-05-16 | -0.5% | legal | SEC EDGAR | CODX 8-K: 5.02 and (SEC Filing) |
| 2024-11-08 | -0.5% | earnings | Seeking Alpha | Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript |
| 2021-07-09 | -0.4% | legal | SEC EDGAR | CODX 8-K: 5.02 (SEC Filing) |
| 2022-06-16 | -0.4% | legal | SEC EDGAR | CODX 8-K: 1.01 and (SEC Filing) |
| 2025-05-07 | +0.3% | earnings | Seeking Alpha | Co-Diagnostics Q1 2025 Earnings Preview |
| 2025-01-10 | -0.3% | news | Investing.com | Co-Diagnostics faces potential Nasdaq delisting over share price - Investing.com |
| 2026-04-10 | -0.2% | news | Cổng thông tin điện tử tỉnh Lào Cai | Will Co-Diag (CODX) Stock Recover Soon | Price at $1.39, Down 3.47% - Blue Chip Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-10 | -0.2% | news | Cổng thông tin điện tử Tỉnh Sơn La | Will Co-Diag (CODX) Stock Recover Soon | Price at $1.39, Down 3.47% - Blue Chip Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-26 | — | analyst | MSN | CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - MSN |